UK biotech MiNA Therapeutics has signed up another big pharma partner for its small activating RNA (saRNA) platform, which upregulates the activity of proteins, with Eli Lilly the latest to get in ...
GlobalData on MSN9d
AB2 Bio and Nippon Shinyaku enter Tadekinig alfa licensing dealAB2 Bio has made an option and licencing agreement with Nippon Shinyaku, granting the latter the option to obtain exclusive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback